The CBSE Class 12 Biology curriculum is divided into four main units, each carrying equal weight in the final 70-mark theory ...

Buck Institute’s deployment of Nautilus’ instrument generates tau proteoform data, providing external validation of the company’s ...

Vancouver, Canada, November 4th, 2025, FinanceWire Equity Insider News Commentary – The precision medicine sector reached ...

PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced that it will host a virtual event on Wednesday, November 12, ...

The collaboration between the University and CyanoCapture will focus on developing innovative methods for producing targeted delivery systems using engineered carboxysomes, combining advanced ...

Discover eight key AI biotech deals that have been made so far in 2025, spotlighting where industry leaders are betting big.

So while it was once the subject of high school biology classes ... the best known application of the molecule, researchers ...

Inherited diseases should not dictate human fate. Today, with advances in genomics, a different future is within reach. In this new era of genomic medicine, Manhattan Genomics, led by serial biotech ...

Electra Therapeutics is a late-stage biotechnology company developing new medicines for people with serious immunological and cancer-related diseases Financing was co-led by EQT ...

Oral presentation to share first-of-its-kind longitudinal gene expression data in IgA nephropathy, unveiling novel insights into the mechanism of action of felzartamab and advancing the understanding ...

Onward Therapeutics SA, a clinical stage oncology company, today announced that its French subsidiary, Onward Therapeutics France, has exercised its exclusive option and entered into a worldwide ...

Detailed price information for Nautilus Biotechnology Inc (NAUT-Q) from The Globe and Mail including charting and trades.